We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is Ventas (VTR) Up 10.9% Since Last Earnings Report?
Read MoreHide Full Article
It has been about a month since the last earnings report for Ventas (VTR - Free Report) . Shares have added about 10.9% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Ventas due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
Ventas' Q1 FFO & Revenues Beat Estimates on NOI Growth
Ventas reported first-quarter 2019 normalized FFO of 99 cents, beating the Zacks Consensus Estimate of 96 cents. However, the figure comes in lower than the year-ago tally of $1.05.
The company witnessed higher rental income from its office and triple net leased portfolio.
Ventas posted revenues of $942.9 million, which surpassed the Zacks Consensus Estimate of $919.2 million. The revenue figure, however, compares unfavorably with the year-ago number of $943.7 million.
Quarter in Detail
For the first quarter, same-store cash NOI growth for the total property portfolio (1,139 assets) inched up 1.1% year over year. Segment wise, same-store cash NOI for the triple net leased portfolio grew 2.2%, the office portfolio rose 3.8%, while seniors-housing operating portfolio registered a decline of 2.2%.
During the quarter, Ventas opened Sutter Van Ness medical office building (MOB), its trophy MOB development in Downtown San Francisco. The property, spanning 239,000 square feet of space is anchored by Sutter Health, is currently 83% leased.
Liquidity
Ventas exited first-quarter 2019 with cash and cash equivalents of around $82.5 million, up from $72.3 million as of the prior-quarter end.
Outlook
Ventas reiterated its 2019 normalized FFO per share outlook of $3.75-$3.85. The 2019 Nareit FFO is expected in the range of $3.70-$3.82.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in fresh estimates.
VGM Scores
Currently, Ventas has an average Growth Score of C, a grade with the same score on the momentum front. Charting a somewhat similar path, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Ventas has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Is Ventas (VTR) Up 10.9% Since Last Earnings Report?
It has been about a month since the last earnings report for Ventas (VTR - Free Report) . Shares have added about 10.9% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Ventas due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
Ventas' Q1 FFO & Revenues Beat Estimates on NOI Growth
Ventas reported first-quarter 2019 normalized FFO of 99 cents, beating the Zacks Consensus Estimate of 96 cents. However, the figure comes in lower than the year-ago tally of $1.05.
The company witnessed higher rental income from its office and triple net leased portfolio.
Ventas posted revenues of $942.9 million, which surpassed the Zacks Consensus Estimate of $919.2 million. The revenue figure, however, compares unfavorably with the year-ago number of $943.7 million.
Quarter in Detail
For the first quarter, same-store cash NOI growth for the total property portfolio (1,139 assets) inched up 1.1% year over year. Segment wise, same-store cash NOI for the triple net leased portfolio grew 2.2%, the office portfolio rose 3.8%, while seniors-housing operating portfolio registered a decline of 2.2%.
During the quarter, Ventas opened Sutter Van Ness medical office building (MOB), its trophy MOB development in Downtown San Francisco. The property, spanning 239,000 square feet of space is anchored by Sutter Health, is currently 83% leased.
Liquidity
Ventas exited first-quarter 2019 with cash and cash equivalents of around $82.5 million, up from $72.3 million as of the prior-quarter end.
Outlook
Ventas reiterated its 2019 normalized FFO per share outlook of $3.75-$3.85. The 2019 Nareit FFO is expected in the range of $3.70-$3.82.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in fresh estimates.
VGM Scores
Currently, Ventas has an average Growth Score of C, a grade with the same score on the momentum front. Charting a somewhat similar path, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Ventas has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.